WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, ...
Experts call for urgent action to turn around an "unacceptable" decline in testing for a disease that kills 20 people every ...
Memphis residents say they're already grappling for clean air after Elon Musk’s AI company began pumping out plumes of ...
Sanofi sees continued growth and strong financials despite a pipeline setback. Click for this updated look at SNY stock ...
As long as you can work with it, and it’s not affecting your life that much, you don’t consider yourself disabled.” ...
The best thing since sliced bread. That's how patient and former volunteer Lori Gasca describes Tri City Health Partnership, ...
A Massachusetts man in his 40s has been diagnosed with silicosis, an incurable lung disease linked to popular kitchen ...
The UCR accepts referrals from GPs, Hampshire hospitals, ambulance services, families, and patients themselves. It helps ...
GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...
GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments ...
An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this ...
GSK PLC on Friday said the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended the approval of depemokimab in two indications. The London-based pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback